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Human papillomavirus (HPV) has a well-recognized aetiological role in the development of
cervical cancer and other anogenital tumours. Recently, an association between colorectal cancer
and HPV infection has been suggested, although this is still controversial. This study aimed at
detecting and characterizing HPV infection in 57 paired biopsies from colorectal cancers and
adjacent intact tissues using a degenerate PCR approach. All amplified fragments were
genotyped by means of sequencing. Overall, HPV prevalence was 12.3%. In particular, 15.8% of
tumour tissues and 8.8% of non-cancerous tissue samples were HPV DNA-positive. Of these
samples, 85.7% were genotyped successfully, with 41.7% of sequences identifying four
genotypes of the HR (high oncogenic risk) clade Group 1; the remaining 58.3% of HPV-
genotyped specimens had an unclassified b-HPV. Examining additional cases and analysing
whole genomes will help to outline the significance of these findings.
The aetiological role of human papillomavirus (HPV) in
cervical and anogenital cancers is well recognized. Recent
clinical and laboratory evidence has highlighted the asso-
ciation between HPV infection and the development of
other malignancies, such as head and neck cancer, and skin
tumours (HPV Information Centre, 2014; IARC, 2011).
Papillomaviruses are small epitheliotropic viruses that
infect all vertebrates, including humans. HPVs are grouped
into five genera, Alphapapillomavirus, Betapapillomavirus,
Gammapapillomavirus,Mupapillomavirus andNupapillomavirus,
with Alphapapillomavirus and Betapapillomavirus being
associated primarily with benign and malignant lesions of
the mucosal and cutaneous epithelia. The International
Agency for Research on Cancer (IARC) classification
includes 25 alphapapillomavirus genotypes in the HR (high
oncogenic risk) clade due to their association with
malignancy; however, insufficient evidence is available to
exclude other genotypes from this risk (IARC, 2011).
Colorectal cancer is one of the most common tumours in
the world (Jemal et al., 2011), but its pathogenesis remains
poorly understood. Colorectal carcinogenesis is a multistep
process that involves genetic instability, DNA repair defects,
aberrant DNA methylation and mutational inactivation of
tumour suppressor genes. Specifically, inactivation of the
tumour suppressor protein p53 has been implicated in
carcinogenesis (Kanthan et al., 2012). As the HPV protein
E6 efficiently inactivates p53, HPV has the potential to
contribute to colorectal cancer development (Moody &
Laimins, 2010). However, the association between HPV
infection and colorectal cancer is still controversial (Damin
et al., 2013; Gornick et al., 2010; Lorenzon et al., 2011);
several studies report a prevalence of HPV infection ranging
from 0 to 84.2% (Damin et al., 2013).
Here, we report the presence of HPV and the unexpected
evidence of an unclassified b-HPV in paraffin-embedded
colorectal cancer tissues collected for a wider ongoing
study aimed at evaluating the role of HPV infection in the
etiopathogenesis of colorectal cancer.
Between March 2011 and September 2012, 57 patients (26
women, 31 men; mean age 72 years; range 34–91 years)
with colorectal adenocarcinoma histologically diagnosed at
the IRCCS AOU San Martino-IST, Genoa, Italy, were
biopsied. A total of 114 paraffin-embedded specimens,
including 57 colorectal tumours and 57 paired samples of
The GenBank/EMBL/DDBJ accession numbers for the L1 sequences
of the unclassified b-HPV are KJ680282–KJ680288.
One supplementary table is available with the online Supplementary
Material.
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adjacent intact tissue (non-cancerous colorectal tissue from
an area located 15 cm proximally to the tumour) were
analysed to detect HPV DNA. Specimens were collected
and prepared in accordance with good laboratory practice
in order to avoid the possibility of HPV contamination.
Ethics approval was obtained from the Ethics Committee
of IRCCS San Martino Hospital, Genoa, Italy (19/2011).
Slices (10 mm thick) from the paraffin-embedded tissues
were used to detect HPV DNA. Samples were pretreated to
remove paraffin before DNA extraction. Briefly, one 10 mm
section was dissolved in 800 ml lysis buffer (bioMe´rieux)
and incubated for 10 min at 100 uC in a dry bath under
agitation. The lysate was centrifuged at 14462 g for 5 min,
and 400 ml of the lower phase (the cellular com-
ponents) was recovered and stored at 220 uC until DNA
extraction using an automated system for total nucleic acid
extraction (NucliSENS1 easyMAG1; bioMe´rieux) accord-
ing to the manufacturer’s instructions.
The paired samples of tumour and adjacent intact tissue
were simultaneously subjected to extraction, together with
a positive control (paraffin-embedded tissue from an HPV-
16-positive cervical cancer) and a negative control (water).
The concentration and purity of the extracted DNA were
evaluated using a NanoDrop 2000c spectrophotometer
(Thermo Fisher Scientific). DNA integrity was assessed by
amplification of a 268 bp fragment in the ubiquitous b-
globin gene (Puranen et al., 1996).
HPV DNA was detected using in-house nested PCR
amplification of a 150 bp segment of the L1 ORF. Degener-
ate ELSI-f/ELSI-r (outer) and GP5+/GP6+ (inner) primer
pairs were used for the first and second amplification steps,
respectively. Each PCR run included negative (water) and
positive controls (DNA extracted from Caski cells)
(de Roda Husman et al., 1995; Tanzi et al., 2013).
To obtain 450 bp fragments suitable for genotyping, DNA
extracted from HPV-positive samples was subjected to 40
cycles of amplification using the degenerate primer pair
ELSI-f/ELSI-r (Tanzi et al., 2013).
Amplicons obtained were purified with NucleoSpin1
Extract II (Macherey-Nagel). L1 gene nucleotide sequences
were aligned with the reference sequences in GenBank
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and Papillomavirus
Episteme (PaVE; http://pave.niaid.nih.gov/#home) using the
public bioinformatics program BLAST.
Furthermore, phylogenetic analysis was performed using
the optimal substitution model HKY+G, selected by
jModelTest (version 2.0) and three different approaches: a
neighbour-joining (NJ) method implemented in the MEGA
package (version 4.0), a maximum-likelihood method by
PhyML (version 3.0) and a Bayesian method using MrBayes
(version 3.2). Bootstrap analysis (number of replicates:
n51000 using NJ and n5200 using PhyML) was performed
to test tree robustness. Posterior probabilities (PPs) were
used for internal node significance on Bayesian trees.
Strict precautions were taken to avoid potential contam-
ination at each step of the study, including specimen
preparation and analytical processing.
The purity, quality and integrity of the extracted DNA were
confirmed for all samples.
Overall, HPV DNA was detected in 12.3% [14/114; 95%
confidence interval (CI) 7.2–19.3] of the samples analysed:
specifically, in 15.8% (9/57; 95% CI 8.5–27.4) of tumour
tissues and 8.8% (5/57; 95% CI 3.3–18.4) of non-
cancerous tissue samples (Table 1). HPV DNA was never
detected in both types of sample from the same patient.
Twelve out of 14 (85.7%) HPV DNA-positive samples
were genotyped successfully by sequencing and analysed
using BLAST. Five (41.7%) of the sequences showed four
genotypes of the HR clade Group 1: HPV-16 (N51),
HPV-18 (N51), HPV-33 (N51) and HPV-58 (N52)
(Table 1).
Table 1. HPV DNA detection and genotyping in tumour (T) and adjacent intact non-cancerous tissues (P), broken down by
anatomical site
Anatomical site T–P pairs
[N (%)]
HPV DNA-positive
[N (%)]/T;P [n (%)]
HPV genotypes in tumour
tissue (N)
HPV genotypes in adjacent
intact tissue (N)
Colon* 82 (71.9)
(41 pairs)
11 (13.4)
7;4 (17.1;9.8)
HPV-16 (1), HPV-33 (1),
unclassified b-HPV (4),
untypable HPV (1)
HPV-58 (1),
unclassified b-HPV (2),
untypable HPV (1)
Rectum 20 (17.6)
(10 pairs)
2 (10)
2;0 (20;0)
HPV-58 (1),
unclassified b-HPV (1)
Sigmoid rectum 12 (10.5)
(six pairs)
1 (8.3)
0;1 (0;16.7)
HPV-18 (1)
Total 114 (100)
(57 pairs)
14 (12.3)
9;5 (15.8;8.8)
HPV-16 (1), HPV-33 (1), HPV-58 (1),
unclassified b-HPV (5),
untypable HPV (1)
HPV-18 (1), HPV-58 (1),
unclassified b-HPV (2),
untypable HPV (1)
*Proximal colon (caecum, ascending, transverse) and distal colon (descending, sigmoid).
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Notably, the L1 fragment of the remaining seven se-
quences (58.3%) showed a high similarity with both
the clone DL369 (de Villiers et al., 1999) and Italy/1552*/
2011 (La Rosa et al., 2013) sequences (similarity range 86–
99%), matching an unclassified genotype of the genus
Betapapillomavirus. Furthermore, a similarity range of 72–
75% with b-HPV-107 was obtained by using PaVE.
To better characterize these seven unclassified isolates, we
also performed a phylogenetic analysis with 43 Betapapil-
lomavirus reference sequences in GenBank and PaVE, and
clone DL369 and Italy/1552*/2011 to reconstruct three
phylogenetic trees (Fig. 1, Table S1, available in the online
Supplementary Material). The unclassified HPV did not
cluster with the genotype HPV-107, but formed a highly
significant clade with clone DL369 and Italy/1552*/2011 in
all three phylogenetic analyses, supported by bootstrap
values of 99 (NJ) and 87.5% (PhyML), and PP51
(Bayesian tree).
Identifying the involvement of a viral infection in colorec-
tal tumours could improve our understanding of tumour
pathogenesis, widen diagnostic capabilities and identify
prevention strategies.
We found HPV infection in 24.6% (14/57) of patients with
colorectal cancer. In particular, considering the patients
broken down by anatomical site of the tumour (cancerous
tissue together with adjacent intact tissue), the highest
frequency of HPV positivity was detected in the colon (11/
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Fig. 1. Bayesian phylogenetic tree depicting the relationships of seven unclassified L1 gene sequences with several reference
sequences of b-HPV genotypes. Numbers on the internal nodes indicate PPs.
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41, 26.8%). Among the identified sequences, 41.7%
belonged to genotypes of the HR clade Group 1, which is
classified as carcinogenic to humans. The remaining 58.3%
fell into the genus Betapapillomavirus and showed a
similarity range of 72–75% with the L1 fragment of b-
HPV-107. According to the guidelines for papillomavirus
nomenclature (http://www.ictvonline.org/) and the clas-
sification proposed by de Villiers et al. (2004), sequences
showing a nucleotide similarity of 89–98% throughout the
L1 ORF fit within the same genotype. Thus, the b-HPV
sequences found in our samples cannot be classified as
HPV-107. The close evolutionary relationship with the
Italy/1552*/2011 sequence, which is found in urban
wastewater in Italy (La Rosa et al., 2013), could support
the hypothesis that the spread of HPV in urban wastewater
is associated with faecal contamination and the presence of
the virus in the human intestine.
The detection of b-HPV was made possible by the use of
a degenerate primer pair, designed on the high con-
served L1 gene, potentially able to amplify HPV geno-
types included in other genera, other than the genus
Alphapapillomavirus.
Our study is limited by the short fragment (450 bp) of the
HPV genome we analysed. Thus, we merely described the
identification of sequences of a new unclassified b-HPV
genotype. In order to classify our sequences as a new b-
HPV genotype, sequencing of the entire genome is
necessary. However, it should be noted that we used
paraffin-embedded tissues. DNA degradation occurs fre-
quently with this type of sample preservation, resulting in
poor amplification of large genomic fragments.
To delineate the significance of our findings, in-depth
molecular and phylogenetic analyses will be performed
on fresh tissue samples collected from a wider selection
of cases from patients with or without colorectal cancer.
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